Screener
Mineralys Therapeutics, Inc. MLYS Q2 2026 earnings
Reported August 12, 2026 · After market close
EPS-$2.85Miss by $2.30
EPS estimate-$0.55
Next report
Nov 9, 2026 (in 2 months)EPS estimate-$0.53
Versus estimates
Diluted EPS
FAQ
- When did Mineralys Therapeutics, Inc. report Q2 2026 earnings?
- Mineralys Therapeutics, Inc. (MLYS) reported Q2 2026 earnings on August 12, 2026 after market close.
- What were Mineralys Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Mineralys Therapeutics, Inc. reported eps of $-2.85 for Q2 2026.
- Did Mineralys Therapeutics, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.55 by $2.30.
- How did Mineralys Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 331.8% from $-0.66.
- Where can I find Mineralys Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001933414-26-000112) and the 10-Q periodic report (0001933414-26-000114) directly on SEC EDGAR. The filing index links above go to sec.gov.
